NCT03856151

Brief Summary

The aim of this study is to investigate the effects of heating device among otherwise stable patients with intradialytic hypotension

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 27, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 17, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2021

Completed
Last Updated

September 16, 2021

Status Verified

January 1, 2019

Enrollment Period

1 year

First QC Date

February 11, 2019

Last Update Submit

September 10, 2021

Conditions

Keywords

hemodialysisIntra-dialytic Hypotensionheating deviceelectronic moxibustion

Outcome Measures

Primary Outcomes (2)

  • change of frequency of IDH episodes

    times of IDH episode according to NADIR, KDOQI criteria

    baseline, Treatment 1, Treatment 2

  • change of number of nursing interventions during HD

    Trendelenburg position, man¬ual reduction of ultrafiltration rate, infusion of isotonic saline or hypertonic fluid, lowering of dialysate temperature

    baseline, Treatment 1, Treatment 2

Secondary Outcomes (4)

  • change of the degree of cold intolerance

    week 0,4,6,10

  • change of the degree of fatigue after dialysis

    before and after Treatment1 & 2

  • blood pressure changes

    baseline, Treatment 1, Treatment 2

  • change of recovery time from fatigue after dialysis

    before and after Treatment1 & 2

Study Arms (2)

Group 1

ACTIVE COMPARATOR

For Group 1, each subject will receive Treatment 1# first. Then, it takes 2-week washout period with regular dialysis 3 times per week and then receive Treatment 2#. Treatment 1# will be regular dialysis 3 times per week for 4 weeks. Treatment 2# will be regular dialysis 3 times per week plus "HEALTHY BOX" Powered heating pad on acupoint CV4 at the abdomen for 1 hour during dialysis, also for 4 weeks.

Device: "HEALTHY BOX" Powered heating pad (electronic moxibustion)

Group 2

ACTIVE COMPARATOR

For Group 2, each subject will receive Treatment 2# first. Then, it takes 2-week washout period with regular dialysis 3 times per week and then receive Treatment 1#. Treatment 2# will be regular dialysis 3 times per week plus "HEALTHY BOX" Powered heating pad on acupoint CV4 at the abdomen for 1 hour during dialysis, also for 4 weeks. Treatment 1# will be regular dialysis 3 times per week for 4 weeks.

Device: "HEALTHY BOX" Powered heating pad (electronic moxibustion)

Interventions

Using heating pad (electronic moxibustion) with insulating materials on low temperatures (56±8℃) in treating patients with intra-dialytic hypotension

Group 1Group 2

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 20 to 80-years-old
  • Willing to sign inform consent
  • Weekly hemodialysis 3 times per week, each time at least 180 minutes
  • During the past 2 months of hemodialysis, there is symptomatic intra-dialytic hypotension for over 15% of the time or under regular use of Midodrine.

You may not qualify if:

  • Pregnancy or breast-feeding
  • Not able to fill out questionnaires
  • Severe comorbidities, including cirrhosis, heart failure, autoimmune diseases and cancer
  • Diabetic peripheral neuropathy or patients insensitive to heat or unable to effectively express themselves in heated situations
  • Undergoing other types of alternative treatment, including Chinese medicine and regional remedies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keelung Chang Gung Memorial Hospital

Keelung, 20401, Taiwan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: 30 eligible participants diagnosed with IDH will be enrolled and divided randomly and equally into Group 1 and Group 2 . Treatment 1# will be regular dialysis 3 times per week for 4 weeks. Treatment 2# will be regular dialysis 3 times per week plus "HEALTHY BOX" Powered heating pad on acupoint CV4 at the abdomen for 1 hour during dialysis, also for 4 weeks. For Group 1, each subject will receive Treatment 1# first, for Group 2, Treatment 2# will be received first. Then, a 2-week washout period with regular dialysis 3 times per week will be carried out. Group 1 will then receive Treatment 2# and Group 2 will then receive Treatment 1#. Subjective questionnaires will be done before and after each Treatment period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2019

First Posted

February 27, 2019

Study Start

April 17, 2019

Primary Completion

April 20, 2020

Study Completion

April 28, 2021

Last Updated

September 16, 2021

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

1. There will be a research number representing the identity. This number will not display the name, ID number, and address. 2. For the results and diagnosis of the visit, the research host will maintain a confidential attitude and carefully maintain the privacy. If research results are published, the identity will remain confidential. 3. Please also understand that if the participant signs the consent form, the participant agrees that the visit record can be directly reviewed by the monitor, auditor, research ethics committee and the competent authority to ensure that the research process and data comply with relevant laws and regulations. These people also promise not to violate the confidentiality of your identity.

Locations